 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Tirzepatide, A New Antidiabetic Drug with Change in the Treatment of Patients with Type 2 Diabetes |
| Soo Kyoung Kim |
|
J Korean Diabetes. 2022;23(4):213-216. Published online December 31, 2022 DOI: https://doi.org/10.4093/jkd.2022.23.4.213 |
|
Tirzepatide, A New Antidiabetic Drug with Change in the Treatment of Patients with Type 2 Diabetes The Journal of Korean Diabetes. 2022;23(4):213-216  Factors Affecting Noninsulin Antidiabetic Drug Adherence in Patients with Type 2 Diabetes Diabetes. 2018;67(Supplement_1): Change in pharmacodynamic variables following once‐weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (
Diabetes, Obesity and Metabolism. 2022;25(2):398-406 Weight change and health care resource use (HCRU) in english patients with type 2 diabetes mellitus (T2DM) initiating a new antidiabetic drug class Value in Health. 2014;17(3):A252 PDB30 Assessment of the Impact of the New Antidiabetic Treatment with Vildagliptin to Change the Total Costs on Diabetes Type 2 Value in Health. 2011;14(7):A477 Effects of long-term treatment with stevioside on the type 2 diabetic Goto-Kakizaki (GK) rats: - Potential as a new antidiabetic drug Diabetes Research and Clinical Practice. 2000;50:393 Tirzepatide, a new class of incretin-based drug for diabetes Obesity Medicine. 2023;39:100483 Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight International Journal of Clinical Practice. 2007;61:19-28 Baseline Characteristics, Weight and Glycaemic Change Among Patients in the United Kingdom with Type 2 Diabetes Mellitus (T2DM) Prescribed a New Antidiabetic Treatment Class in a Real World Setting Value in Health. 2013;16(7):A432 Antidiabetic drug treatment confounds gut dysbiosis associated with type 2 diabetes mellitus Nature Reviews Endocrinology. 2015;12(2):61-61 |
